RGL-270 + ICI in Advanced NSCLC

NCT07652125 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

40

Enrollment

OTHER

Sponsor class

Conditions

NSCLC

Interventions

BIOLOGICAL: RGL-270 in Combination with PD-1/PD-L1 Inhibitors
OTHER: Physician's Choice SOC

Sponsor

Guangdong Association of Clinical Trials

Collaborators

[object Object]